Need help finding what you are looking for?
Contact Us
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1304270
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1304270
Drug and Gene Delivery Devices Market, By Product, By Commercialized Drugs (Luxturna, Yescarta, Zolgensma, Kymriah, Provenge, and Strimvelis ), and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
PUBLISHED:
PAGES: 155 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The field of drug and gene delivery involves the development and delivery of drugs, genes, and/or gene products that ultimately alter protein expression and function of the cells, tissues, and living organisms. Drug delivery devices are the tools used to deliver the drug through the specific route of administration. While, gene delivery is the process of introducing foreign genetic material, such as DNA or RNA, into host cells.
Market Dynamics:
Rise in burden of chronic diseases, such as infectious disease, cardiovascular disease, cancer, and diabetes, increasing demand for drug or gene delivery devices, increasing funding for cell and gene therapies, and rise in approvals for gene therapies are major factors expected to augment the growth of the global drug and gene delivery devices market over the forecast period.
For instance, in November 2022, Imunon, Inc. and Acuitas Therapeutics signed an agreement to evaluate the combination of IMUNON's PLACCINE nucleic acid vaccine constructs formulated with Acuitas' proprietary lipid delivery technology. Under the agreement, IMUNON will evaluate administration of its vector constructs formulated in various Acuitas LNP formulations for gene expression and immunogenicity in murine models.
Key features of the study:
- This report provides in-depth analysis of the global drug and gene delivery devices market, and provides market size (US$ Thousand) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global drug and gene delivery devices market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Pfizer, Inc., Novartis AG, Kite Pharma, Inc., Bluebird bio, Inc., Becton, Amgen, Inc., Vericel Corporation, uniQure N.V., Spark Therapeutics, Inc., Renova Therapeutics, Orchard Therapeutics plc, Kolon Tissue Gene, Inc., Human Stem Cell Institute, Dendreon Pharmaceuticals, Dickinson and Company, Helixmith Co., Ltd (ViroMed Co., Ltd), Bausch & Lomb Incorporated, and Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.), among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global drug and gene delivery devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug and gene delivery devices market.
Detailed Segmentation:
- Global Drug and Gene Delivery Devices Market, By Product:
- Sub-retinal Injection Cannula
- Extension Tube
- Intravenous Catheter
- Sterile Insulin Syringe
- Pre-filled Syringe
- Infusion Bags
- Global Drug and Gene Delivery Devices Market, By Commercialized Drugs:
- Luxturna (Drug Delivery Devices)
- Yescarta (Drug Delivery Devices)
- Zolgensma (Drug Delivery Devices)
- Kymriah (Drug Delivery Devices)
- Provenge (Drug Delivery Devices)
- Strimvelis (Drug Delivery Devices)
- Global Drug and Gene Delivery Devices Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Company Profiles:
- Pfizer, Inc.
- Novartis AG
- Kite Pharma, Inc.
- Bluebird bio, Inc.
- Becton Dickinson and Company
- Amgen, Inc.
- Vericel Corporation
- uniQure N.V.
- Spark Therapeutics, Inc.
- Renova Therapeutics
- Orchard Therapeutics plc
- Kolon Tissue Gene, Inc.
- Human Stem Cell Institute
- Dendreon Pharmaceuticals
- Helixmith Co., Ltd (ViroMed Co., Ltd.)
- Bausch & Lomb Incorporated
- Castle Creek Biosciences, Inc. (Fibrocell Technologies, Inc.)
Product Code: CMI5864
Table of Contents:
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Commercialized Drugs
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Rise in burden of chronic diseases across the globe
- Stringent rules and regulations
- Increasing demand for drug and gene delivery devices
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Drug and Gene Delivery Devices Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Drug and Gene Delivery Devices Market, By Product, 2018-2030, (US$ Thousand)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Sub-retinal Injection Cannula
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Thousand)
- Extension Tube
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Thousand)
- Intravenous Catheter
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Thousand)
- Sterile Insulin Syringe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Thousand)
- Pre-filled Syringe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Thousand)
- Infusion Bags
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Thousand)
6. Global Drug and Gene Delivery Devices Market, By Commercialized Drugs, 2018-2030, (US$ Thousand)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Luxturna (Drug Delivery Devices)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Thousand)
- Yescarta (Drug Delivery Devices)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Thousand)
- Zolgensma (Drug Delivery Devices)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Thousand)
- Kymriah (Drug Delivery Devices)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Thousand)
- Provenge (Drug Delivery Devices)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Thousand)
- Strimvelis (Drug Delivery Devices)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Thousand)
7. Global Drug and Gene Delivery Devices Market, By Region, 2018-2030, (US$ Thousand)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Thousand)
- Market Size and Forecast, and Y-o-Y Growth, By Commercialized Drugs, 2018-2030,(US$ Thousand)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Thousand)
- Market Size and Forecast, and Y-o-Y Growth, By Commercialized Drugs, 2018-2030,(US$ Thousand)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Thousand)
- Market Size and Forecast, and Y-o-Y Growth, By Commercialized Drugs, 2018-2030,(US$ Thousand)
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Thousand)
- Market Size and Forecast, and Y-o-Y Growth, By Commercialized Drugs, 2018-2030,(US$ Thousand)
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Thousand)
- Market Size and Forecast, and Y-o-Y Growth, By Commercialized Drugs, 2018-2030,(US$ Thousand)
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Thousand)
- Market Size and Forecast, and Y-o-Y Growth, By Commercialized Drugs, 2018-2030,(US$ Thousand)
8. Competitive Landscape
- Pfizer, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Kite Pharma, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bluebird bio, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Vericel Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- uniQure N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Spark Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Renova Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Orchard Therapeutics plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Kolon Tissue Gene, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Human Stem Cell Institute
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Amgen, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Dendreon Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Helixmith Co.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bausch & Lomb Incorporated, Ltd. (ViroMed Co., Ltd.)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Becton Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Castle Creek Biosciences, Inc. (Fibrocell Technologies, Inc.)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
9. Section
- Research Methodology
- About us
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.